Bioventus Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	992	499	690	333	162	863
Market Cap Growth	138.70%	-27.70%	107.09%	105.83%	-81.23%	-
Enterprise Value	1,238	786.26	1,022	738.83	636.85	1,251
Last Close Price	11.89	7.44	10.50	5.27	2.61	14.49
PE Ratio	28.73	22.55	-	-	-	-
Forward PE	14.63	9.79	20.00	21.82	17.17	21.50
PEG Ratio	1.33	0.82	0.82	0.82	0.82	2.07
PS Ratio	1.71	0.88	1.20	0.65	0.32	2.00
PB Ratio	4.15	2.71	4.67	1.92	0.50	1.88
P/FCF Ratio	9.80	6.92	18.27	41.77	-	91.11
P/OCF Ratio	9.58	6.69	17.80	21.73	-	37.53
EV/Sales Ratio	2.15	1.38	1.78	1.44	1.24	2.90
EV/EBITDA Ratio	15.31	7.79	29.75	-	-	26.66
EV/EBIT Ratio	20.55	14.57	-	-	-	103.76
EV/FCF Ratio	12.31	10.90	27.05	92.56	-	132.14
Debt / Equity Ratio	1.08	1.22	1.66	1.66	0.93	0.64
Debt / EBITDA Ratio	2.62	2.91	9.77	-	-	7.62
Debt / FCF Ratio	2.70	4.08	8.88	49.47	-	37.77
Net Debt / Equity Ratio	1.25	1.32	1.99	2.06	1.19	0.68
Net Debt / EBITDA Ratio	2.27	2.40	8.56	-14.69	-3.47	6.69
Net Debt / FCF Ratio	2.35	3.37	7.78	44.84	-25.83	33.13
Asset Turnover	0.86	0.80	0.75	0.47	0.39	0.50
Inventory Turnover	4.34	-	4.05	2.09	2.47	2.82
Quick Ratio	1.06	1.12	0.80	0.91	0.55	0.93
Current Ratio	1.69	1.70	1.31	1.53	0.90	1.45
Return on Equity (ROE)	14.93%	26.35%	-46.27%	-100.05%	-75.70%	6.21%
Return on Assets (ROA)	8.85%	8.11%	-1.78%	-7.49%	-9.85%	1.69%
Return on Invested Capital (ROIC)	12.54%	12.04%	-2.58%	-11.86%	-15.53%	2.66%
Return on Capital Employed (ROCE)	11.22%	10.37%	-2.64%	-9.59%	-15.82%	1.70%
Earnings Yield	2.89%	4.44%	-	-	-	-
FCF Yield	10.21%	14.45%	5.47%	2.39%	-	1.10%
Buyback Yield / Dilution	-7.22%	-6.77%	-3.03%	-2.05%	-35.00%	11.70%
Total Shareholder Return	-7.22%	-6.77%	-3.03%	-2.05%	-35.00%	11.70%

SEC Filings: 10-K · 10-Q